Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pivonello

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Journal of Endocrinological Investigation|February 18, 2006
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative studyS Grottoli, R Celleno, V Gasco, et al.
Journal of Endocrinological Investigation|April 22, 2006
Potential indications for somatostatin analogues: immune system and limphoproliferative disordersD Ferone, E Resmini, M Boschetti, et al.
Journal of Endocrinological Investigation|July 3, 2010
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analoguesM C De Martino, R S Auriemma, G Brevetti, et al.
Journal of Endocrinological Investigation|February 28, 2026
Management of andrological disorders from childhood and adolescence to transition age: guidelines from the Italian Society of Andrology and Sexual Medicine (SIAMS) in collaboration with the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP) - part-2Marco Bonomi, A Balsamo, C Bizzarri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic malesC Di Somma, A Colao, A Di Sarno, et al.
Journal of Endocrinological Investigation|August 4, 2005
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of ageA Colao, S Spiezia, C Di Somma, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkageA Colao, A Di Sarno, M L Landi, et al.
Journal of Endocrinological Investigation|July 18, 2019
The treatment with pasireotide in Cushing's disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single centerC Simeoli, R Ferrigno, M C De Martino, et al.
Minerva Endocrinologica|February 26, 2013
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literatureM Galdiero, P Vitale, C Simeoli, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidusA De Bellis, A Colao, A Bizzarro, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Journal of Endocrinological Investigation|February 18, 2006
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative studyS Grottoli, R Celleno, V Gasco, et al.
Journal of Endocrinological Investigation|April 22, 2006
Potential indications for somatostatin analogues: immune system and limphoproliferative disordersD Ferone, E Resmini, M Boschetti, et al.
Journal of Endocrinological Investigation|July 3, 2010
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analoguesM C De Martino, R S Auriemma, G Brevetti, et al.
Journal of Endocrinological Investigation|February 28, 2026
Management of andrological disorders from childhood and adolescence to transition age: guidelines from the Italian Society of Andrology and Sexual Medicine (SIAMS) in collaboration with the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP) - part-2Marco Bonomi, A Balsamo, C Bizzarri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic malesC Di Somma, A Colao, A Di Sarno, et al.
Journal of Endocrinological Investigation|August 4, 2005
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of ageA Colao, S Spiezia, C Di Somma, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkageA Colao, A Di Sarno, M L Landi, et al.
Journal of Endocrinological Investigation|July 18, 2019
The treatment with pasireotide in Cushing's disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single centerC Simeoli, R Ferrigno, M C De Martino, et al.
Minerva Endocrinologica|February 26, 2013
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literatureM Galdiero, P Vitale, C Simeoli, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidusA De Bellis, A Colao, A Bizzarro, et al.
Pageof 14